David W. Henry
- Oncology top 5%
- Organic Chemistry top 2%
- Molecular Biology top 10%
- Pediatrics, Perinatology and Child Health top 5%
- Cardiology and Cardiovascular Medicine top 10%
- Co-authors
- Michael CoryJoseph A. MillerDavid D. McKeeEdward M. ActonWilliam W. LeeThomas H. SmithAllan N. FujiwaraGeorge L. Tong
- Topics
- Cancer Treatment and Pharmacology (9 papers)Synthesis and Characterization of Heterocyclic Compounds (8 papers)Cancer therapeutics and mechanisms (8 papers)
- Cited by
- ToxicologyOncologyOrganic Chemistry
- Partner nations
- United StatesCanadaSwitzerland
In The Last Decade
David W. Henry
74 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Oncology 810
- Organic Chemistry 766
- Molecular Biology 725
- Pediatrics, Perinatology and Child Health 246
- Cardiology and Cardiovascular Medicine 208
Countries citing papers authored by David W. Henry
This map shows the geographic impact of David W. Henry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David W. Henry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David W. Henry more than expected).
Fields of papers citing papers by David W. Henry
This network shows the impact of papers produced by David W. Henry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David W. Henry. The network helps show where David W. Henry may publish in the future.
Co-authorship network of co-authors of David W. Henry
This figure shows the co-authorship network connecting the top 25 collaborators of David W. Henry. A scholar is included among the top collaborators of David W. Henry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David W. Henry. David W. Henry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 5 | |
| 3 | 5 | |
| 4 | 90 | |
| 5 | 47 | |
| 6 | 16 | |
| 7 | 12 | |
| 8 | 13 | |
| 9 | 87 | |
| 10 | Diagram recognition using hidden Markov models | 2 |
| 11 | 0 | |
| 12 | 12 | |
| 13 | 49 | |
| 14 | 198 | |
| 15 | Design, synthesis, and DNA binding properties of bifunctional intercalators. Comparison of polymethylene and diphenyl ether chains connecting phenanthridinebreakdown → | 416 |
| 16 | Nucleosides, nucleotides, and their biological applications : proceedings of the 5th international round table, October 20-22, 1982 | 6 |
| 17 | 60 | |
| 18 | 30 | |
| 19 | 33 | |
| 20 | 4 |
About David W. Henry
David W. Henry is a scholar working on Organic Chemistry, Physiology and Oncology, having authored 78 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (9 papers), Synthesis and Characterization of Heterocyclic Compounds (8 papers) and Cancer therapeutics and mechanisms (8 papers). The work is most often cited by research in Toxicology (103 citations), Oncology (810 citations) and Organic Chemistry (766 citations). David W. Henry has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Michael Cory, Joseph A. Miller, David D. McKee, Edward M. Acton, William W. Lee, Thomas H. Smith, Allan N. Fujiwara, George L. Tong, Helen Y. Wu and Paul Rogers. Their work appears in journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.